• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估更年期和肥胖对matriptase-2及神经激肽B浓度的影响:一项横断面研究。

Assessing the effects of menopause and obesity on matriptase-2 and neurokinin B concentrations: A cross-sectional study.

作者信息

Bulut Arikan Funda, Sagsoz Nevin

机构信息

Kirikkale University, Faculty of Medicine, Department of Physiology, Kirikkale, Turkey.

Kirikkale University, Faculty of Medicine, Department of Obstetrics and Gynecology, Kirikkale, Turkey.

出版信息

J Med Biochem. 2025 Jun 13;44(3):470-478. doi: 10.5937/jomb0-52348.

DOI:10.5937/jomb0-52348
PMID:40821629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12357639/
Abstract

BACKGROUND

Matriptase-2 (MT2) is implicated in iron metabolism, obesity, insulin resistance, and glucose homeostasis. Neurokinin B (NKB) plays a crucial role in gonadotropin secretion, which is essential for reproduction. The impact of menopause and obesity on MT2 and NKB concentrations remains an enigma. Therefore, the present study sought to investigate how obesity and menopause affect serum concentrations of MT2 and NKB.

METHODS

In this cross-sectional study, 120 female volunteers were divided into four groups: menopausal overweight, menopausal obese, menopausal normal weight (control), and reproductive normal weight (control). The participants' serum levels of MT2, NKB, iron, ferritin, and relevant biochemical parameters were analysed using the ELISA method.

RESULTS

The mean serum concentrations of NKB, MT2, and ferritin were higher in the menopausal overweight and obese groups (p<0.05). The mean concentrations of NKB, MT2, and estradiol were determined to be higher, and the levels of iron, hemoglobin, glucose, FSH, LH, LDL, and total cholesterol were found to be lower in the reproductive control group when compared with the menopausal control group (p<0.05). A positive correlation was identified between BMI and NKB, MT2, and ferritin concentrations in menopausal overweight and obese groups (p<0.05).

CONCLUSIONS

Obesity elevated NKB and MT2 concentrations in menopausal women. The increase in MT2 levels in menopausal overweight or obese women may be one of the factors responsible for the increase in ferritin and body fat ratio. As BMI raised, NKB, MT2, and ferritin concentrations raised in the menopausal overweight or obese groups; therefore, depression of MT2 in obese patients could be beneficial for therapeutic purposes. Additionally, gonadal hormonal changes altered serum concentrations of NKB, and the increase in NKB and gonadotropin levels in menopause may enhance vasomotor symptoms.

摘要

背景

Matriptase-2(MT2)与铁代谢、肥胖、胰岛素抵抗和葡萄糖稳态有关。神经激肽B(NKB)在促性腺激素分泌中起关键作用,促性腺激素分泌对生殖至关重要。绝经和肥胖对MT2和NKB浓度的影响仍是一个谜。因此,本研究旨在探讨肥胖和绝经如何影响血清MT2和NKB浓度。

方法

在这项横断面研究中,120名女性志愿者被分为四组:绝经后超重组、绝经后肥胖组、绝经后正常体重组(对照组)和生育期正常体重组(对照组)。采用ELISA法分析参与者血清中MT2、NKB、铁、铁蛋白及相关生化参数水平。

结果

绝经后超重和肥胖组的NKB、MT2和铁蛋白平均血清浓度较高(p<0.05)。与绝经后对照组相比,生育期对照组的NKB、MT2和雌二醇平均浓度较高,而铁、血红蛋白、葡萄糖、促卵泡激素(FSH)、促黄体生成素(LH)、低密度脂蛋白(LDL)和总胆固醇水平较低(p<0.05)。绝经后超重和肥胖组的体重指数(BMI)与NKB、MT2和铁蛋白浓度之间存在正相关(p<0.05)。

结论

肥胖会使绝经后女性的NKB和MT2浓度升高。绝经后超重或肥胖女性MT2水平的升高可能是铁蛋白和体脂率增加的原因之一。随着BMI升高,绝经后超重或肥胖组的NKB、MT2和铁蛋白浓度升高;因此,降低肥胖患者的MT2水平可能有利于治疗。此外,性腺激素变化会改变血清NKB浓度,绝经后NKB和促性腺激素水平的升高可能会加重血管舒缩症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/d1e33a75c5b1/jomb-44-3-2503470B_g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/1b1e8fe124ff/jomb-44-3-2503470B_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/3773a66eaa9a/jomb-44-3-2503470B_g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/d1e33a75c5b1/jomb-44-3-2503470B_g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/1b1e8fe124ff/jomb-44-3-2503470B_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/3773a66eaa9a/jomb-44-3-2503470B_g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b67/12357639/d1e33a75c5b1/jomb-44-3-2503470B_g003.jpg

相似文献

1
Assessing the effects of menopause and obesity on matriptase-2 and neurokinin B concentrations: A cross-sectional study.评估更年期和肥胖对matriptase-2及神经激肽B浓度的影响:一项横断面研究。
J Med Biochem. 2025 Jun 13;44(3):470-478. doi: 10.5937/jomb0-52348.
2
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
3
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD008452. doi: 10.1002/14651858.CD008452.pub3.
4
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
5
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
6
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
7
Lifestyle intervention for improving school achievement in overweight or obese children and adolescents.改善超重或肥胖儿童及青少年学业成绩的生活方式干预。
Cochrane Database Syst Rev. 2014 Mar 14(3):CD009728. doi: 10.1002/14651858.CD009728.pub2.
8
Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS).用于经前综合征(PMS)的促性腺激素释放激素(GnRH)类似物。
Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD011330. doi: 10.1002/14651858.CD011330.pub2.
9
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.绝经前后阶段女性使用脱氢表雄酮。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD011066. doi: 10.1002/14651858.CD011066.pub2.
10
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.

本文引用的文献

1
Updates in nonhormonal therapy for perimenopausal and menopausal symptoms.围绝经期和绝经症状的非激素治疗进展
Curr Opin Obstet Gynecol. 2025 Apr 1;37(2):67-74. doi: 10.1097/GCO.0000000000001009. Epub 2025 Jan 13.
2
NK2R control of energy expenditure and feeding to treat metabolic diseases.NK2R 控制能量消耗和摄食以治疗代谢疾病。
Nature. 2024 Nov;635(8040):987-1000. doi: 10.1038/s41586-024-08207-0. Epub 2024 Nov 13.
3
Iron homeostasis and insulin sensitivity: unraveling the complex interactions.铁稳态和胰岛素敏感性:揭示复杂的相互作用。
Rev Endocr Metab Disord. 2024 Oct;25(5):925-939. doi: 10.1007/s11154-024-09908-7. Epub 2024 Sep 17.
4
Investigation of the relationship between betatrophin and certain key enzymes involved in carbohydrate and lipid metabolism in insulin-resistant mice.探讨胰岛素抵抗小鼠中 betatrophin 与参与糖脂代谢的某些关键酶之间的关系。
Horm Mol Biol Clin Investig. 2023 Mar 6;44(3):311-320. doi: 10.1515/hmbci-2022-0104. eCollection 2023 Sep 1.
5
Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass.绝经后腹部皮下脂肪组织表型的变化与内脏脂肪量增加有关。
Sci Rep. 2021 Jul 20;11(1):14750. doi: 10.1038/s41598-021-94189-2.
6
Effects of Ovariectomy and Sex Hormone Replacement on Numbers of Kisspeptin-, Neurokinin B- and Dynorphin A-immunoreactive Neurons in the Arcuate Nucleus of the Hypothalamus in Obese and Diabetic Rats.卵巢切除术和性激素替代对肥胖及糖尿病大鼠下丘脑弓状核中 kisspeptin、神经激肽 B 和强啡肽 A 免疫反应性神经元数量的影响
Neuroscience. 2020 Dec 15;451:184-196. doi: 10.1016/j.neuroscience.2020.10.003. Epub 2020 Oct 14.
7
Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA).神经激肽 3 受体拮抗剂 fezolinetant 对绝经后血管舒缩症状患者报告结局的影响:一项随机、安慰剂对照、双盲、剂量范围研究(VESTA)的结果。
Menopause. 2020 Dec;27(12):1350-1356. doi: 10.1097/GME.0000000000001621.
8
TRPV2 POLYMORPHISMS INCREASE OR REDUCE THE RISK OF TYPE 2 DIABETES - HASHIMOTO THYROIDITIS COMORBIDITY.瞬时受体电位香草酸亚型2(TRPV2)基因多态性增加或降低2型糖尿病合并桥本甲状腺炎的发病风险。
Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):15-21. doi: 10.4183/aeb.2020.15.
9
Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.用神经激肽 3 受体拮抗剂非佐利奈坦治疗绝经血管舒缩症状:一项 2a 期试验。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5893-5905. doi: 10.1210/jc.2019-00677.
10
Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.近年来 II 型跨膜丝氨酸蛋白酶、hepsin、matriptase 和 matriptase-2 抑制剂的研究进展。
Future Med Chem. 2019 Apr;11(7):743-769. doi: 10.4155/fmc-2018-0446. Epub 2019 Apr 4.